Cargando…
1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
OBJECTIVE: To determine whether prostate artery embolization (PAE) is a cost-effective alternative to transurethral resection of the prostate (TURP) in the management of benign prostate hyperplasia (BPH) after 1-year follow-up. DESIGN, SETTING AND MAIN OUTCOME MEASURES: A retrospective cost-utility...
Autores principales: | Patel, Nikisha, Yung, Nathan, Vigneswaran, Ganesh, de Preux, Laure, Maclean, Drew, Harris, Mark, Somani, Bhaskar, Bryant, Timothy, Hacking, Nigel, Modi, Sachin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749306/ https://www.ncbi.nlm.nih.gov/pubmed/35047801 http://dx.doi.org/10.1136/bmjsit-2020-000071 |
Ejemplares similares
-
Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study
por: Vigneswaran, Ganesh, et al.
Publicado: (2021) -
Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
por: Abt, Dominik, et al.
Publicado: (2018) -
Does Prostate Artery Embolization (PAE) Improve Voiding Symptoms, Storage Symptoms, or Both?
por: Maclean, Drew, et al.
Publicado: (2019) -
Comprehensive Review on Current Controversies and Debate in Prostate Artery Embolization
por: Maclean, Drew, et al.
Publicado: (2022) -
Can Metabolic Disorders in Aging Men Contribute to Prostatic Hyperplasia Eligible for Transurethral Resection of the Prostate (TURP)?
por: Rył, Aleksandra, et al.
Publicado: (2015)